Ngā hua rapu - Jean-Louis Lefèbvre
- E whakaatu ana i te 1 - 8 hua o te 8
-
1
Current clinical outcomes demand new treatment options for SCCHN mā Jean Louis Lefèbvre
I whakaputaina 2005Revisão -
2
Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma mā C. Domenge, Catherine Hill, Jean Louis Lefèbvre, D. De Raucourt, B. Rhein, P. Wibault, P Marandas, Bernard Coche‐Dequeant, M Stromboni-Luboinski, H Sancho-Garnier, B Luboïnski
I whakaputaina 2000Artigo -
3
Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer mā Jacques Bernier, C. Domenge, Mahmut Özsahin, Katarzyna Łukawska‐Matuszewska, Jean-Louis Lefèbvre, Richard Greiner, J. Giralt, P. Maingon, Frédéric Rolland, M. Bolla, F. Cognetti, Jean Bourhis, Anne Kirkpatrick, M. van Glabbeke
I whakaputaina 2004Artigo -
4
Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer mā Jan B. Vermorken, Éva Remenár, Carla van Herpen, Thierry Gorlia, Ricard Mesı́a, M. Degardin, John S. Stewart, S. Jelić, Jan Betka, Joachim H. Preiss, Daniëlle Van den Weyngaert, Ahmad Awada, Didier Cupissol, H. Kienzer, A Rey, Isabelle Desaunois, Jacques Bernier, Jean-Louis Lefèbvre
I whakaputaina 2007Artigo -
5
Phase 3 Randomized Trial on Larynx Preservation Comparing Sequential vs Alternating Chemotherapy and Radiotherapy mā Jean Louis Lefèbvre, Frédéric Rolland, Margot Tesselaar, É. Bardet, C. René Leemans, Lionnel Geoffrois, P. Hupperets, Luigi Barzan, D. De Raucourt, Dominique Chevalier, Lisa Licitra, F Lunghi, Roger Stupp, Denis Lacombe, Jan Bogaerts, Jean-Claude Horiot, J. Bernier, Jan B. Vermorken
I whakaputaina 2009Artigo -
6
Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: Is it necessary for all? mā Phillip K. Pellitteri, Alfio Ferlito, Alessandra Rinaldo, Jatin P. Shah, Randal S. Weber, John Lowry, Jesús E. Medina, Christine G. Gourin, K. Thomas Robbins, Carlos Suárez, Ashok R. Shaha, Eric M. Genden, C. René Leemans, Jean Louis Lefèbvre, Luiz Paulo Kowalski, WI Wei
I whakaputaina 2005Revisão -
7
Induction Chemotherapy Followed by Either Chemoradiotherapy or Bioradiotherapy for Larynx Preservation: The TREMPLIN Randomized Phase II Study mā Jean Louis Lefèbvre, Y. Pointreau, Frédéric Rolland, M. Alfonsi, A Baudoux, C. Sire, D. De Raucourt, O. Malard, M. Degardin, C. Tuchais, Emmanuel Blot, M. Rives, Émile Reyt, Jean Marc Tourani, L. Geoffrois, Fréderic Peyrade, F. Guichard, Dominique Chevalier, E. Babin, Philippe Lang, François Janot, G. Calais, P. Garaud, É. Bardet
I whakaputaina 2013Artigo -
8
American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer mā David G. Pfister, Scott A. Laurie, Gregory S. Weinstein, William M. Mendenhall, David J. Adelstein, K. Kian Ang, Gary L. Clayman, Susan G. Fisher, Arlene A. Forastiere, Louis B. Harrison, Jean‐Louis Lefebvre, Nancy E. Leupold, Marcy A. List, Bernard O’Malley, Snehal G. Patel, Marshall R. Posner, Michael Schwartz, Gregory T. Wolf
I whakaputaina 2006Revisão
Ngā utauta rapu:
Ngā marau whai pānga
Internal medicine
Medicine
Surgery
Cancer
Chemotherapy
Radiation therapy
Oncology
Randomized controlled trial
Cisplatin
Fluorouracil
Head and neck cancer
Induction chemotherapy
Larynx
Chemoradiotherapy
Clinical trial
Concomitant
Disease
Docetaxel
Head and neck
Laryngectomy
Pathology
Alternative medicine
Biology
Cetuximab
Clinical endpoint
Colorectal cancer
Dissection (medical)
Guideline
Intensive care medicine
Multidisciplinary approach